Skip to main navigation
LinkedIn Twitter
  • Investors
  • Careers
Outlook Therapeutics, Inc. Logo
  • About
    • Overview
    • Senior Leadership
    • Board of Directors
  • Pipeline
    • ONS-5010 / LYTENAVA™ OVERVIEW
    • ONS-5010 CLINICAL PROGRESS
    • UNMET PATIENT NEEDS
    • REPACKAGED IV BEVACIZUMAB
    • NEW OPHTHALMIC ANTI-VEGF
    • POTENTIAL FIRST-LINE THERAPY
  • News
  • Contact

Committee Composition

Home / Investors / Corporate Governance / Committee Composition

Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Gerd Auffarth, MD Nominating and Corporate Governance Committee
Julian Gangolli Audit Committee
Yezan Haddadin Compensation Committee
Julia A. Haller, MD Nominating and Corporate Governance Committee
Kurt J. Hilzinger Audit Committee Compensation Committee
Faisal G. Sukhtian Nominating and Corporate Governance Committee
Randy Thurman Audit Committee Compensation Committee
= Chairperson = Member = Financial Expert
  • Investor Overview
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Other Shareholder Information
  • Financial Information
    • SEC Filings
  • Analyst Coverage
  • News & Events
    • Press Releases
    • Events
    • In the News
    • Presentations
  • Corporate Governance
    • Governance Highlights
    • Board Diversity Disclosure
    • Senior Leadership
    • Board of Directors
    • Committee Composition
  • Information Request
  • Print Page Print Page
  • Email Page Email Page
  • RSS Feeds RSS Feeds
  • Email Alerts Email Alerts
  • Contact IR Contact IR
© 2023 Outlook Therapeutics, Inc.
Privacy Policy | Disclaimer